QA: Verastem Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001526119_2023_Verastem_Inc.pdf

Logs

Graph

Absolute values for 0001526119, Verastem Inc.

  xvar xval
0 AssetsCurrent 92,870,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 92,000
3 remainder_Assets 2,088,000
4 LiabilitiesCurrent 21,663,000
5 LiabilitiesNoncurrent 1,470,000
6 remainder_Liabilities 24,526,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 24,975,000
9 ResearchAndDevelopmentExpense 50,558,000
10 remainder_Expenses 2,137,000
11 remainder_Revenues 2,596,000
12 remainder_NetIncome 1,262,000
13 remainder_ComprehensiveNetIncome -34,000
  yvar yval
0 Assets 95,050,000
1 Liabilities 47,659,000
2 Expenses 77,670,000
3 Revenues 2,596,000
4 StockholdersEquity 47,391,000
5 NetIncome -73,812,000
6 ComprehensiveNetIncome -73,829,000
7 BaseVar 112,135,500
8 EconomicCapitalRatio 0.108

Edgar->Model Mapping

Feature Distribution

Change over Time